Here are four things to know about the company’s performance:
1. Philips reported its sales remained constant at €4.3 billion (an estimated $5 billion) for the second quarter, compared to a similar estimated €4.3 billion in sales during the same period last year.
2. The company posted €1.8 billion (an estimated $2.1 billion) in sales for its diagnosis and treatment business segment, up 5 percent from the second quarter of 2017. The segment reported strong growth in the company’s image-guided therapy and ultrasound solutions.
3. Philips reported €743 million (an estimated $866.6 million) in sales for its connected care and health informatics business segment, down 3 percent from the same period last year. The segment saw growth from its healthcare informatics solutions, along with its monitoring and analytics tools.
4. The company posted a net income from continuing operations of €186 million (an estimated $216.9 million) during the second quarter, up 15 percent from €161 million (an estimated $187.8 million) one year prior.
More articles on health IT:
Half of ‘All of Us’ participants are underrepresented minorities, NIH chief says
700K paper records breached in 2018 — More than half attributed to 1 break-in
16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
